CoChat

Neurofilament light chain level is a weak risk factor for the development of MS

Open access
Arrambide, Georgina, Espejo, Carmen, Eixarch, Herena, Villar, Luisa M., Alvarez-Cermeño, José C., Picón, Carmen, Kuhle, Jens, Disanto, Giulio, Kappos, Ludwig, Sastre-Garriga, Jaume, Pareto, Deborah, Simon, Eva, Comabella, Manuel, Río, Jordi, Nos, Carlos, Tur, Carmen, Castilló, Joaquín, Vidal-Jordana, Angela, Galán, Ingrid, Arévalo, Maria J., Auger, Cristina, Rovira, Alex, Montalban, Xavier, Tintore, Mar · 2016 · Neurology
Cited by 110

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To determine the prognostic value of selected biomarkers in clinically isolated syndromes (CIS) for conversion to multiple sclerosis (MS) and disability accrual. METHODS: Data were acquired from 2 CIS cohorts. The screening phase evaluated patients developing clinically definite MS (CIS-CDMS) and patients who remained as CIS during a 2-year minimum follow-up (CIS-CIS). We determined levels of neurofascin, semaphorin 3A, fetuin A, glial fibrillary acidic protein, and neurofilament light (NfL) and heavy chains in CSF (estimated mean [95% confidence interval; CI]). We evaluated associations between biomarker levels, conversion, disability, and magnetic resonance parameters. In the replication phase, we determined NfL levels (n = 155) using a 900 ng/L cutoff. Primary endpoints in uni- and multivariate analyses were CDMS and 2010 McDonald MS. RESULTS: The only biomarker showing significant differences in the screening was NfL (CIS-CDMS 1,553.1 [1,208.7-1,897.5] ng/L and CIS-CIS 499.0 [168.8-829.2] ng/L, p < 0.0001). The strongest associations were with brain parenchymal fraction change (rs = -0.892) and percentage brain volume change (rs = -0.842) at 5 years. NfL did not correlate with disability. In the replication phase, more NfL-positive patients, according to the cutoff, evolved to MS. Every 100-ng/L increase in NfL predicted CDMS (hazard ratio [HR] = 1.009, 95% CI 1.005-1.014) and McDonald MS (HR = 1.009, 95% CI 1.005-1.013), remaining significant for CDMS in the multivariate analysis (adjusted HR = 1.005, 95% CI 1.000-1.011). This risk was lower than the presence of oligoclonal bands or T2 lesions. CONCLUSIONS: NfL is a weak independent risk factor for MS. Its role as an axonal damage biomarker may be more relevant as suggested by its association with medium-term brain volume changes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000003085

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 110

Metadata

Authors
Arrambide, G., Espejo, C., Eixarch, H., Villar, L. M., Alvarez-Cermeño, J. C., Picón, C., Kuhle, J., Disanto, G., Kappos, L., Sastre-Garriga, J., Pareto, D., Simon, E., Comabella, M., Río, J., Nos, C., Tur, C., Castilló, J., Vidal-Jordana, A., Galán, I., Arévalo, M. J., Auger, C., Rovira, A., Montalban, X., & Tintore, M.
Venue
Neurology
Published
2016-09-13
Volume
87
Issue
11
Pages
1076-1084
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2509699065
Cited by
110
References
7
FWCI
11.20
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurofilament light chain level is a weak risk factor for the development of MS. https://app.cochat.ai/papers/10.1212/wnl.0000000000003085
The paper
Arrambide, G., Espejo, C., Eixarch, H., Villar, L. M., Alvarez-Cermeño, J. C., Picón, C., Kuhle, J., Disanto, G., Kappos, L., Sastre-Garriga, J., Pareto, D., Simon, E., Comabella, M., Río, J., Nos, C., Tur, C., Castilló, J., Vidal-Jordana, A., Galán, I., . . . Tintore, M. (2016). Neurofilament light chain level is a weak risk factor for the development of MS. Neurology. https://doi.org/10.1212/wnl.0000000000003085

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.